retardation, and bulbar/pseudobulbar signs. The recent study showed that these clinical symptoms and signs may vary according to age at onset and GFAP mutation site.
Introduction
Alexander disease, first described by W. Stewart Alexander in 1949, 1) is a rare neurodegenerative disorder caused by dominant mutations in the glial fibrillary acidic protein (GFAP) gene. These mutations produce a gain of function in a GFAP protein leading to astrocyte dysfunction, deposition of Rosenthal fibers, and abnormal intracytoplasmic inclusions in astrocytes. Although this rare leukoencephalopathy has been well known for its frequent associations with macrocephaly or megalencephaly, the clinical presentation is rather nonspecific, including seizures, hydrocephalus, megalencephaly, progressive psychomotor addition to the presence of leukodystrophy. Ataxia, hyperreflexia, and other upper motor neuron signs are usually absent in the neonatal form. Furthermore, it may be misdiagnosed as a neoplasm, since enhancing brain stem lesions are also associated with obstructive hydrocephalus.
To confirm the diagnosis of Alexander disease, GFAP se quencing is more widely used than immunohistochemical staining of brain biopsy material. Accordingly, some genotype phenotype correlations have been reported; for example, mutations at residue R79 and R239 were more prevalent in the early onset group. 2, 5) However, there has been limited genotype data regarding the neonatal form of Alexander disease.
In the present study, we report a case of Alexander disease, which could be classified as the neonatal form based on the characteristic clinical features including onset age (50 days), intractable seizures, and obstructive hydrocephalus caused by tumorlike lesion in the tectal area. We also confirmed this diagnosis through genetic testing of GFAP.
Case report
A boy was born at 38 weeks and 5 days gestation via vaginal delivery to nonconsanguineous Korean parents. His birth weight was 2.9 kg (1025 percentile) with no reported head circumference. At the age of 50 days, he had clonic movements in his arms and face, which lasted for about one minute. Initially, this event occurred one or two times per day. However, the frequency of these events gradually increased to up to 10 times per day. He was admitted for evaluation and management of these repeated seizures. Upon admission, head circumference, height, and weight were 40.5 cm (9095 percentile), 60.3 cm (7590 percentile), and 5.3 kg (1025 percentile), respectively. Muscle tone and deep tendon reflexes were slightly decreased symmetrically. Babinski reflexes were present on both sides. Electroencephalography revealed focal epileptiform discharges from the left frontal area. Brain magnetic resonance imaging (MRI) revealed dilatation of both lateral ventricles and the third ventricle. Abnormally high T2 weighted signal intensity was noted in the periventricular white matter, basal ganglia, and midbrain including the tectum. The tectal lesion also showed focal enhancement with enlargement ( Fig. 1A and B) . Initially, the suspected diagnosis was a congenital infection such as cytomegalovirus or tectal glioma causing obstructive hydrocephalus. Endoscopic third ventriculostomy was per formed as management for hydrocephalus. Although ventricular dilatation improved in subsequent brain MRIs, the extent of periventricular white matter, basal ganglia, and midbrain lesions increased with rapidly progressive cortical atrophy (Fig.  1CF ). Seizures were refractory to multiple anti epileptic drugs. Head circumference measured at 5 months was 46 cm (> 97 percentile). After rereviewing the clinical features and brain MRI findings, Alexander disease was suggested as a possible diagnosis. Subsequent direct sequencing of GFAP confirmed a de novo missense mutation (c.1096T>C, Y366H; Fig. 2 ), which has been reported previously. 5) At his last followup visit at 28 months, psychomotor development was severely retarded; the patient could neither control his head, nor fix and follow an object. He was completely bedridden, fed via a gastric tube, and dependent on a home ventilator.
Discussion
Alexander disease is classically described as a leukoen cephalopathy with macrocephaly; however, considerable variation exists in the clinical manifestation of this rare disease. While infantile or early onset Alexander disease is characterized by progressive psychomotor regression, ataxia, and prominent upper motor neuron signs, the neonatal form has somewhat different clinical features as reported in a limited number of patient cases. Springer et al. reported 3 cases of Alexander disease with neonatal onset, 4) summarized as having the following differentiating clinical features: intractable seizures, rapid progression, hydrocephalus with intracranial pressure primarily caused by aqueductal stenosis, as well as absence of hyperreflexia and spasticity. Although the onset of the case discussed here was slightly delayed until after the neonatal period (50 days old), the overall clinical features of this case were more consistent with the neonatal form of Alexander disease. Specifically, obstructive hydrocephalus with a tectal masslike enhancing lesion was consistent with the diagnosis of a brain tumor, which would be unusual for this age but still included in the differential diagnosis. These atypical clinical features delayed the ultimate diagnosis of Alexander disease, which was suspected only after the progression of white matter signals was identified on serial brain MRIs. Subsequently, we confirmed the diagnosis of Alexander disease by GFAP sequencing. A recent comprehensive genotypephenotype correlation study found that half of all mutations found in Alexander dis ease affected 1 of 4 amino acids in the GFAP peptide residue (R79, R88, R239, and R416).
2) They also reported that the pa tients with R79 and R239 mutations tended to have seizures, macrocephaly, and classic radiologic features at an early age of onset. However, 
